Skip to main content
Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · IEX Real-Time Price · USD
14.20
+1.20 (9.23%)
At close: Apr 24, 2024, 4:00 PM
14.14
-0.06 (-0.42%)
After-hours: Apr 24, 2024, 6:22 PM EDT

Avalo Therapeutics Market Cap

Avalo Therapeutics has a market cap or net worth of $14.68 million as of April 24, 2024. Its market cap has decreased by -62.92% in one year.

Market Cap
14.68M
Enterprise Value
7.32M
1-Year Change
-62.92%
Ranking
#5146
Category
Nano-Cap
Stock Price
$14.20

Market Cap Chart

Since November 13, 2015, Avalo Therapeutics's market cap has decreased from $34.50M to $14.68M, a decrease of -57.44%. That is a compound annual growth rate of -9.61%.

History

DateMarket Cap% Change
Apr 23, 202410.40M6.12%
Apr 22, 20249.80M5.38%
Apr 19, 20249.30M-3.13%
Apr 18, 20249.60M-11.93%
Apr 17, 202410.90M-14.84%
Apr 16, 202412.80M4.92%
Apr 15, 202412.20M2.52%
Apr 12, 202411.90M-5.56%
Apr 11, 202412.60M4.13%
Apr 10, 202412.10M4.31%
Apr 9, 202411.60M1.75%
Apr 8, 202411.40M-12.98%
Apr 5, 202413.10M-
Apr 4, 202413.10M-
Apr 3, 202413.10M7.38%
Apr 2, 202412.20M-14.69%
Apr 1, 202414.30M-17.82%
Mar 28, 202417.40M357.89%
Mar 27, 20243.80M2.70%
Mar 26, 20243.70M-5.13%
Mar 25, 20243.90M-
Mar 22, 20243.90M5.41%
Mar 21, 20243.70M2.78%
Mar 20, 20243.60M2.86%
Mar 19, 20243.50M-2.78%
View and export this data all the way back to 2015. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
NeuroBo Pharmaceuticals 15.21M
T2 Biosystems 15.17M
Mainz Biomed B.V. 15.05M
BioSig Technologies 14.78M
Pieris Pharmaceuticals 14.75M
ETAO International Co. 14.39M
Immuron 14.19M
Trinity Biotech 14.14M
Market Cap Rankings